How can toxicogenomics inform risk assessment?

Toxicology and Applied Pharmacology

Volumn 207, Issue 2 SUPPL., 2005, Pages 592-598

  Oberemm, Axel ^a   Onyon, Lesley ^b   Gundert Remy, Ursula ^a  

^a FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Mechanistic toxicology; Risk assessment; Toxicogenomics

Indexed keywords

BIOCHEMICAL MARKER;

BIOINFORMATICS; CONFERENCE PAPER; DNA MICROARRAY; DNA POLYMORPHISM; EXPOSURE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOMICS; GENOTOXICITY; GENOTYPE ENVIRONMENT INTERACTION; HEALTH HAZARD; HUMAN; INTERNATIONAL COOPERATION; METABOLOMICS; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RISK ASSESSMENT; RNA TRANSLATION; TOXICOGENETICS; TRANSCRIPTOMICS;

ANIMALIA;

EID: 24644471614     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2005.01.044     Document Type: Conference Paper

References (60)

1. L. Anderson, and J. Seilhamer A comparison of selected mRNA and protein abundances in human liver Electrophoresis 18 1997 533 537
2. N.L. Anderson, J.P. Hofmann, A. Gemmell, and J. Taylor Global approaches to quantitative analysis of gene-expression patterns observed by use of two-dimensional gel electrophoresis Clin.Chem. 30 1984 2031 2036
3. N.L. Anderson, F.A. Giere, S.L. Nance, M.A. Gemmell, S.L. Tollaksen, and N.G. Anderson Effects of toxic agents at the protein level: quantitative measurement of 213 mouse liver proteins following xenobiotic treatment Fundam. Appl. Toxicol. 8 1987 39 50
4. N.L. Anderson, D.C. Copple, R.A. Bendele, G.S. Probst, and F.C. Richardson Covalent protein modifications and gene expression changes in rodent liver following administration of methapyrilene: a study using two-dimensional electrophoresis Fundam. Appl. Toxicol. 18 1992 570 580
5. L. Anderson, V.K. Steele, G.J. Kelloff, and S. Sharma Effects of oltipraz and related chemoprevention compounds on gene expression in rat liver J. Cell Biochem. 22 1995 108 116 (Suppl.)
6. [Anon]. Genomics, transcript profiling, proteomics and metabonomics (GTPM): an introduction. Document No. 42. 2001. Brussels, European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC).
7. A.M. Ardekani, E.H. Herman, F.D. Sistare, L.A. Liotta, and E.F. Petricoin Molecular profiling of cancer and drug-induced toxicity using new proteomic technologies Curr. Ther. Res.-Clin. Exp. 62 2001 803 819
8. Birnbaum, L., Damstra, T., Hart, J., Hedtke, S., Kroes, R., MacPhail, R., Marafante, E., Munns, W., Ross, P., Reiter, L., Sekizawa, J., Suter, G., Van Der Kraak, G., Veith, G., Vermeire, T., Waters, M. Integrated risk assessment. WHO/IPCS/IRA/01/12. 2001. Geneva, WHO/UNEP/ILO International Programme on Chemical Safety. Ref Type: Report
9. U.A. Bölsterli Mechanistic Toxicology-The Molecular Basis of How Chemicals Disrupt Biological Targets 2003 Taylor and Francis London
10. M.E. Burczynski, M. McMillian, J. Ciervo, L. Li, J.B. Parker, R.T. Dunn, S. Hicken, S. Farr, and M.D. Johnson Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells Toxicol. Sci. 58 2000 399 415
11. H.J. Clewell The application of physiologically-based pharmacokinetic modeling in human health risk assessment of hazardous substances Toxicol. Lett. 79 1995 207 217
12. M. Coen, E.M. Lenz, J.K. Nicholson, I.D. Wilson, F. Pognan, and J.C. Lindon An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy Chem. Res. Toxicol. 16 2003 295 303
13. R.B. Conolly, and M.E. Andersen Biologically based pharmacodynamic models-Tools for toxicological research and risk assessment Annu. Rev. Pharmacol. Toxicol. 31 1991 503 523
14. G.L. Corthals, V.C. Wasinger, D.F. Hochstrasser, and J.C. Sanchez The dynamic range of protein expression: a challenge for proteomic research Electrophoresis 21 2000 1104 1115
15. J.C. Corton, S.P. Andersen, A.J. Stauber, D.B. Janszen, J.S. Kimbell, and R.B. Conolly Entering the era of toxicogenomics with DNA microarrays CIIT Act. 1999 19
16. M.L. Cunningham, M.S. Bogdanffy, T.R. Zacharewski, and R.N. Hines Workshop overview: use of genomic data in risk assessment Toxicol. Sci. 73 2003 209 215
17. P. Cutler Protein arrays: the current state-of-the-art Proteomics 3 2003 3 18
18. H. Ellinger-Ziegelbauer, B. Stuart, B. Wahle, W. Bomann, and H.J. Ahr Characteristic expression profiles induced by genotoxic carcinogens in rat liver Toxicol. Sci. 77 2004 19 34
19. S. Farr, and R.T. Dunn Concise review: gene expression applied to toxicology Toxicol. Sci. 50 1999 1 9
20. M.R. Fielden, and T.R. Zacharewski Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology Toxicol. Sci. 60 2001 6 10
21. U. Gundert-Remy, and C. Sonich-Mullin The use of toxicokinetic and toxicodynamic data in risk assessment: an international perspective Sci. Total Environ. 288 2002 3 11
22. H.K. Hamadeh, R.P. Amin, R. Paules, and C. Afshari An overview of toxicogenomics Curr. Issues Mol. Biol. 4 2002 45 56
23. H.K. Hamadeh, P.R. Bushel, S. Jayadev, K. Martin, O. DiSorbo, S. Sieber, L. Bennett, R. Tennant, R. Stoll, J.C. Barrett, K. Blanchard, R.S. Paules, and C.A. Afshari Gene expression analysis reveals chemical-specific profiles Toxicol. Sci. 67 2002 219 231
24. Q.Y. He, and J.F. Chiu Proteomics in biomarker discovery and drug development J. Cell. Biochem. 89 2003 868 886
25. T. Hu, D.P. Gibson, G.J. Carr, S.M. Torontali, J.P. Tiesman, J.G. Chaney, and M.J. Aardema Identification of a gene expression profile that discriminates indirect-acting genotoxins from direct-acting genotoxins Mutat. Res. 549 2004 5 27
26. T. Inoue Toxicogenomics-A new paradigm in Toxicology T. Inoue W. Pennie Toxicogenomics 2003 Springer Tokyo 3 6
27. H.J. Issaq, T.D. Veenstra, T.P. Conrads, and D. Felschow The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification Biochem. Biophys. Res. Comm. 292 2002 587 592
28. J.C. Lindon, J.K. Nicholson, E. Holmes, and J.R. Everett Metabonomics: metabolic processes studied by NMR spectroscopy of biofluids Concepts Magn. Reson. 12 2000 289 320
29. A. Maier, R.E. Savage, and L.T. Haber Assessing biomarker use in risk assessment-A survey of practitioners J. Toxicol. Environ. Health, Part A 67 2004 687 695
30. W.J. Man, I.R. White, D. Bryant, P. Bugelski, P. Camilleri, P. Cutler, G. Heald, P.G. Lord, J. Wood, and K. Kramer Protein expression analysis of drug-mediated hepatotoxicity in the Sprague-Dawley rat Proteomics 2 2002 1577 1585
31. M.A. Medinsky The application of physiologically-based pharmacokinetic/pharmacodynamic (Pbpk/Pd) modeling to understanding the mechanism of action of hazardous substances Toxicol. Lett. 79 1995 185 191
32. M.E. Meek, A. Renwick, E. Ohanian, M. Dourson, B. Lake, B.D. Naumann, and V. Vu Guidelines for application of chemical-specific adjustment factors in dose/concentration-response assessment Toxicology 181 2002 115 120
33. I. Meineke, J. Eisele, H. Certa, and U.M. Gundert-Remy Modelling of residual variability in toxicokinetic studies with sparse sampling: the case of tetrahydronaphthalene Arch. Toxicol. 72 1998 807 810
34. D.B. Menzel Extrapolating the future-research trends in modeling Toxicol. Lett. 79 1995 299 303
35. B.A. Merrick, and K.B. Tomer Toxicoproteomics: a parallel approach to identifying biomarkers Environ. Health Perspect. 111 2003 A578 A579
36. K.T. Morgan Gene expression analysis reveals chemical-specific profiles Toxicol. Sci. 67 2002 155 156
37. J.K. Nicholson, J. Connelly, J.C. Lindon, and E. Holmes Metabonomics: a platform for studying drug toxicity and gene function Nat. Rev., Drug Discov. 1 2002 153 161
38. E.F. Nuwaysir, M. Bittner, J. Trent, J.C. Barrett, and C.A. Afshari Microarrays and toxicology: the advent of toxicogenomics Mol. Carcinog. 24 1999 153 159
39. A. Oberemm, C. Meckert, L. Brandenburger, A. Herzig, Y. Lindner, K. Kalenberg, E. Krause, C. Ittrich, A. Kopp-Schneider, K. Riecke, R. Stahlmann, H.B. Richter-Reichhelm, and U. Gundert-Remy Differential signatures of protein expression in marmoset liver and thymus induced by single-dose TCDD treatment Toxicology 206 2005 33 48
40. G. Orphanides, and I. Kimber Toxicogenetics: applications and opportunities Toxicol. Sci. 75 2003 1 6
41. W.D. Pennie, N.J. Woodyatt, T.C. Aldridge, and G. Orphanides Application of genomics to the definition of the molecular basis for toxicity Toxicol. Lett. 120 2001 353 358
42. E.F. Petricoin, J.L. Hackett, L.J. Lesko, R.K. Puri, S.I. Gutman, K. Chumakov, J. Woodcock, D.W. Feigal, K.C. Zoon, and F.D. Sistare Medical applications of microarray technologies: a regulatory science perspective Nat. Genet. 32 2002 474 479
43. T. Rabilloud Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains Proteomics 2 2002 3 10
44. D.E. Robinson, S.D. Pettit, and D.G. Morgan Use of Genomics in mechanism based risk assessment T. Inoue W.D. Pennie Toxicogenomics 2003 Springer-Verlag Tokyo 194 203
45. Z. Rui, J. Jian-Guo, T. Yuan-Peng, P. Hai, and R. Bing-Gen Use of serological proteomic methods to find biomarkers associated with breast cancer Proteomics 3 2003 433 439
46. C.W. Schmidt Toxicogenomics-An emerging discipline Environ. Health Perspect. 110 2002 A750 A755
47. P.T. Simmons, and C.J. Portier Toxicogenomics: the new frontier in risk analysis Carcinogenesis 23 2002 903 905
48. L.L. Smith Key challenges for toxicologists in the 21st century Trends Pharmacol. Sci. 22 2001 281 285
49. C. Sonich-Mullin, R. Fielder, J. Wiltse, K. Baetcke, J. Dempsey, R. Fenner-Crisp, D. Grant, M. Hartley, A. Knaap, D. Kroese, I. Mangelsdorf, E. Meek, J.M. Rice, and M. Younes IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis Regul. Toxicol. Pharmacol. 34 2001 146 152
50. S. Steiner, D. Wahl, M. Varela, L. Aicher, and P. Prieto Protein variability in male and female Wistar rat liver proteins Electrophoresis 16 1995 1969 1976
51. S. Steiner, L. Aicher, J. Raymackers, L. Meheus, R. EsquerBlasco, N.L. Anderson, and A. Cordier Cyclosporine a decreases the protein level of the calcium-binding protein calbindin-D 28kDa in rat kidney Biochem. Pharmacol. 51 1996 253 258
52. R.W. Tennant The national center for toxicogenomics: using new technologies to inform mechanistic toxicology Environ. Health Perspect. 110 2002 A8 A10
53. M. Toraason, M. Andersen, M.S. Bogdanffy, D. Dankovic, E. Faustman, P. Foster, C. Frederick, L. Haber, C.A. Kimmel, S. Lewis, R. McClellan, R. Melnick, F. Mirer, K. Morgan, V. Schaeffer, E. Silbergeld, W. Slikker, J. Swenberg, and H. Vainio Improving risk assessment: toxicological research needs Hum. Ecol. Risk Assess. 8 2002 1405 1419
54. R.G. Ulrich, J.C. Rockett, G.G. Gibson, and S.D. Pettit Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression Environ. Health Perspect. 112 2004 423 427
55. J.F. Waring, and D.N. Halbert The promise of toxicogenomics Curr. Opin. Mol. Ther. 4 2002 229 235
56. J.F. Waring, R. Ciurlionis, R.A. Jolly, M. Heindel, and R.G. Ulrich Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity Toxicol. Lett. 120 2001 359 368
57. J.F. Waring, R.A. Jolly, R. Ciurlionis, P.Y. Lum, J.T. Praestgaard, D.C. Morfitt, B. Buratto, C. Roberts, E. Schadt, and R.G. Ulrich Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles Toxicol. Appl. Pharmacol. 175 2001 28 42
58. M. Waters, G. Boorman, P. Bushel, M. Cunningham, R. Irwin, A. Merrick, K. Olden, R. Paules, J. Selkirk, S. Stasiewicz, B. Weis, B. Van Houten, N. Walker, and R. Tennant Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base Environ. Health Perspect. 111 2003 811 824
59. C.C. Wu, and M.J. MacCoss Shotgun proteomics: tools for the analysis of complex biological systems Curr. Opin. Mol. Ther. 4 2002 242 250
60. L. Zeise, D. Hattis, M. Andersen, A.J. Bailer, S. Bayard, C. Chen, H. Clewell, R. Conolly, K. Crump, D. Dunson, A. Finkel, L. Haber, A.M. Jarabek, R. Kodell, D. Krewski, D. Thomas, T. Thorslund, and J.T. Wassell Improving risk assessment: research opportunities in dose response modeling to improve risk assessment Hum. Ecol. Risk Assess. 8 2002 1421 1444